Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


User Fee Management System Part Of CDER Plans To Enhance IT Capabilities

This article was originally published in The Pink Sheet Daily

Executive Summary

The need to assimilate biosimilar and generic drug user fee programs and a quest for greater efficiency are major drivers of the center’s proposed $88.9 million spending plan on information technology systems in fiscal year 2014.

You may also be interested in...

FDA’s IT Systems Painted With Bull’s-eye By Senate Funding Panel

The Senate Appropriations Committee April 26 approves a $3.9 billion spending plan for the agency in fiscal 2013, providing a $12.5 million boost in Treasury spending over President Obama’s proposed budget, with the extra funds slated for the food and animal drug programs.

FDA’s IT Overhaul Stagnating Despite Massive Spending, GAO Finds

The agency has not been able to get rid of outdated IT systems despite spending more than $160 million to date on a program designed to do that among other goals.

Rx Misbranding Penalties Should Be Stronger To Stop Counterfeiting, FDA Says

Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts